I agree that this site is using cookies. You can find further informations here.
X
Paoletti, Xavier
410  results:
Search for persons X
?
1

AcSé-ESMART, a European precision cancer medicine proof-of-..:

Geoerger, Birgit ; Paoletti, Xavier ; Bautista, Francisco...
Nature Medicine.  29 (2023)  12 - p. 2985-2987 , 2023
Link: https://doi.org/10.1038/..
 
?
2

CA-125 Early Dynamics to Predict Overall Survival in Women ..:

Karamouza, Eleni ; Glasspool, Rosalind M. ; Kelly, Caroline...
Cancers.  15 (2023)  6 - p. 1823 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Artificial intelligence to improve cytology performance in ..:

Lebret, Thierry ; Paoletti, Xavier ; Pignot, Geraldine...
World Journal of Urology.  41 (2023)  9 - p. 2381-2388 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Survival and modelled cancer antigen-125 ELIMination rate c..:

Corbaux, Pauline ; You, Benoit ; Glasspool, Rosalind M....
European Journal of Cancer.  191 (2023)  - p. 112966 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Estimation risk of lymph nodal invasion in patients with ea..:

Guani, Benedetta ; Gaillard, Thomas ; Teo-Fortin, Ly-Ann...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
6

Clinical impact of low-volume lymph node metastases in earl..:

Guani, Benedetta ; Mahiou, Katia ; Crestani, Adrien...
Gynecologic Oncology.  164 (2022)  2 - p. 446-454 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Phase II and biomarker study of programmed cell death prote..:

Pasqualini, Claudia ; Rubino, Jonathan ; Brard, Caroline...
European Journal of Cancer.  150 (2021)  - p. 53-62 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Characteristics and Outcome of SARS-CoV-2 Infection in Canc..:

Basse, Clémence ; Diakite, Sarah ; Servois, Vincent...
JNCI Cancer Spectrum.  5 (2021)  1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
9

Using a new diagnostic tool to predict lymph node metastasi..:

Mimoun, Camille ; Paoletti, Xavier ; Gaillard, Thomas...
PLOS ONE.  16 (2021)  10 - p. e0258783 , 2021
Link: https://doi.org/10.1371/..
 
?
10

Incorporating patient centered benefits as endpoints in ran..:

Kurtz, Jean-Emmanuel ; Gebski, Val ; Sukhin, Vladyslav...
Gynecologic Oncology.  161 (2021)  2 - p. 502-507 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Risks and benefits of anticancer drugs in advanced cancer p..:

Moreau Bachelard, Camille ; Coquan, Elodie ; du Rusquec, Pauline..
EClinicalMedicine.  40 (2021)  - p. 101130 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Re: Clinical Characteristics and Outcomes of COVID-19–Infec..:

Cottu, Paul ; Bozec, Laurence ; Basse, Clémence.
JNCI: Journal of the National Cancer Institute.  113 (2021)  3 - p. 342-343 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Has tumor doubling time in breast cancer changed over the p..:

Dahan, Meryl ; Hequet, Delphine ; Bonneau, Claire..
Cancer Medicine.  10 (2021)  15 - p. 5203-5217 , 2021
Link: https://doi.org/10.1002/..
 
?
14

A benchmark for dose-finding studies with unknown ordering:

Mozgunov, Pavel ; Paoletti, Xavier ; Jaki, Thomas
Biostatistics.  23 (2021)  3 - p. 721-737 , 2021
Link: https://doi.org/10.1093/..
 
?
15

Impact of follow-up on generalized pairwise comparisons for..:

Chamseddine, Ali N. ; Oba, Koji ; Buyse, Marc...
Contemporary Clinical Trials.  105 (2021)  - p. 106400 , 2021
Link: https://doi.org/10.1016/..
 
1-15